{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:13:23Z","timestamp":1770740003057,"version":"3.49.0"},"reference-count":93,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:00:00Z","timestamp":1648598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007076","name":"Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG grant n\u00b0 23151"],"award-info":[{"award-number":["IG grant n\u00b0 23151"]}],"id":[{"id":"10.13039\/501100007076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ocular tumors are a family of rare neoplasms that develop in the eye. Depending on the type of cancer, they mainly originate from cells localized within the retina, the uvea, or the vitreous. Even though current treatments (e.g., radiotherapy, transpupillary thermotherapy, cryotherapy, chemotherapy, local resection, or enucleation) achieve the control of the local tumor in the majority of treated cases, a significant percentage of patients develop metastatic disease. In recent years, new targeting therapies and immuno-therapeutic approaches have been evaluated. Nevertheless, the search for novel targets and players is eagerly required to prevent and control tumor growth and metastasis dissemination. The fibroblast growth factor (FGF)\/FGF receptor (FGFR) system consists of a family of proteins involved in a variety of physiological and pathological processes, including cancer. Indeed, tumor and stroma activation of the FGF\/FGFR system plays a relevant role in tumor growth, invasion, and resistance, as well as in angiogenesis and dissemination. To date, scattered pieces of literature report that FGFs and FGFRs are expressed by a significant subset of primary eye cancers, where they play relevant and pleiotropic roles. In this review, we provide an up-to-date description of the relevant roles played by the FGF\/FGFR system in ocular tumors and speculate on its possible prognostic and therapeutic exploitation.<\/jats:p>","DOI":"10.3390\/ijms23073835","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:28:39Z","timestamp":1648675719000},"page":"3835","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Exploring the FGF\/FGFR System in Ocular Tumors: New Insights and Perspectives"],"prefix":"10.3390","volume":"23","author":[{"given":"Alessandra","family":"Loda","sequence":"first","affiliation":[{"name":"Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7139-3820","authenticated-orcid":false,"given":"Marta","family":"Turati","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2275-4917","authenticated-orcid":false,"given":"Francesco","family":"Semeraro","sequence":"additional","affiliation":[{"name":"Eye Clinic, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1193-8929","authenticated-orcid":false,"given":"Sara","family":"Rezzola","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8979-7068","authenticated-orcid":false,"given":"Roberto","family":"Ronca","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, School of Medicine, University of Brescia, 25123 Brescia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Cholkar, K., Dasari, S.R., Pal, D., and Mitra, A.K. (2013). Eye: Anatomy, physiology and barriers to drug delivery. Ocular Transporters and Receptors, Elsevier.","DOI":"10.1533\/9781908818317.1"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/j.sult.2010.10.009","article-title":"Ocular anatomy and cross-sectional imaging of the eye","volume":"32","author":"Malhotra","year":"2011","journal-title":"Semin. Ultrasound CT MR"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.neuron.2012.10.002","article-title":"The neuronal organization of the retina","volume":"76","author":"Masland","year":"2012","journal-title":"Neuron"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.mric.2006.06.007","article-title":"Anatomy and pathology of the eye: Role of mr imaging and ct","volume":"14","author":"Mafee","year":"2006","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.mcna.2021.02.005","article-title":"Ocular oncology-primary and metastatic malignancies","volume":"105","author":"Williams","year":"2021","journal-title":"Med. Clin. N. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3109\/09273948.2012.702843","article-title":"Genetics of primary intraocular tumors","volume":"20","author":"Wang","year":"2012","journal-title":"Ocul. Immunol. Inflamm."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/eye.2012.252","article-title":"Ocular metastases","volume":"27","author":"Cohen","year":"2013","journal-title":"Eye"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(11)61137-9","article-title":"Retinoblastoma","volume":"379","author":"Dimaras","year":"2012","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jnr.24213","article-title":"Retinoblastoma, the visible cns tumor: A review","volume":"97","author":"Dimaras","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s12098-017-2395-0","article-title":"Retinoblastoma","volume":"84","author":"Rao","year":"2017","journal-title":"Indian J. Pediatr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2174\/1389557515666150722100610","article-title":"Progress in small molecule therapeutics for the treatment of retinoblastoma","volume":"16","author":"Pritchard","year":"2016","journal-title":"Mini. Rev. Med. Chem."},{"key":"ref_12","first-page":"34","article-title":"Clinical management of uveal and conjunctival melanoma","volume":"30","author":"Blum","year":"2016","journal-title":"Oncology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"100800","DOI":"10.1016\/j.preteyeres.2019.100800","article-title":"Uveal melanoma: Towards a molecular understanding","volume":"75","author":"Smit","year":"2020","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2147\/OPTH.S89591","article-title":"Uveal melanoma: Epidemiology, etiology, and treatment of primary disease","volume":"11","author":"Krantz","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00280-019-03860-z","article-title":"Uveal melanoma: Physiopathology and new in situ-specific therapies","volume":"84","author":"Souto","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1758834018757175","DOI":"10.1177\/1758834018757175","article-title":"Treatment of uveal melanoma: Where are we now?","volume":"10","author":"Yang","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1158\/1078-0432.CCR-10-3169","article-title":"Therapeutic implications of the emerging molecular biology of uveal melanoma","volume":"17","author":"Patel","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/cncr.29727","article-title":"Uveal melanoma: From diagnosis to treatment and the science in between","volume":"122","author":"Chattopadhyay","year":"2016","journal-title":"Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10555-017-9663-3","article-title":"The biology of uveal melanoma","volume":"36","author":"Amaro","year":"2017","journal-title":"Cancer Metastasis Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1136\/bjophthalmol-2016-309034","article-title":"Metastatic disease from uveal melanoma: Treatment options and future prospects","volume":"101","author":"Carvajal","year":"2017","journal-title":"Br. J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Tobia, C., Coltrini, D., Ronca, R., Loda, A., Guerra, J., Scalvini, E., Semeraro, F., and Rezzola, S. (2021). An orthotopic model of uveal melanoma in zebrafish embryo: A novel platform for drug evaluation. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121873"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/PAT.0b013e32835c6505","article-title":"Pathology and genetics of uveal melanoma","volume":"45","author":"Griewank","year":"2013","journal-title":"Pathology"},{"key":"ref_23","first-page":"1230","article-title":"Ocular melanoma: An overview of the current status","volume":"6","author":"Jovanovic","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2016.06.001","article-title":"Advances in the management of conjunctival melanoma","volume":"62","author":"Vora","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0039-6109(02)00098-1","article-title":"Ocular melanoma","volume":"83","author":"Char","year":"2003","journal-title":"Surg. Clin. N. Am."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.sjopt.2018.12.008","article-title":"Primary vitreoretinal lymphoma","volume":"33","author":"Kalogeropoulos","year":"2019","journal-title":"Saudi. J. Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.survophthal.2013.12.001","article-title":"Primary intraocular lymphoma","volume":"59","author":"Sagoo","year":"2014","journal-title":"Surv. Ophthalmol."},{"key":"ref_28","first-page":"1301","article-title":"Intraocular lymphoma","volume":"10","author":"Tang","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.2147\/OTT.S315532","article-title":"A comprehensive understanding of choroidal metastasis from lung cancer","volume":"14","author":"Qu","year":"2021","journal-title":"Oncol. Targets Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"574086","DOI":"10.1155\/2015\/574086","article-title":"Ophthalmic metastasis of breast cancer and ocular side effects from breast cancer treatment and management: Mini review","volume":"2015","author":"Georgalas","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wiedlocha, A., Haugsten, E.M., and Zakrzewska, M. (2021). Roles of the fgf-fgfr signaling system in cancer development and inflammation. Cells, 10.","DOI":"10.3390\/cells10092231"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"Fgf\/fgfr signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev. Dev. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The fgf family: Biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","article-title":"Structural basis for fgf receptor dimerization and activation","volume":"98","author":"Plotnikov","year":"1999","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1158\/1078-0432.CCR-11-0699","article-title":"Molecular pathways: Fibroblast growth factor signaling: A new therapeutic opportunity in cancer","volume":"18","author":"Brooks","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.phrs.2016.03.024","article-title":"Blocking the fgf\/fgfr system as a \u201ctwo-compartment\u201d antiangiogenic\/antitumor approach in cancer therapy","volume":"107","author":"Giacomini","year":"2016","journal-title":"Pharmacol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ferguson, H.R., Smith, M.P., and Francavilla, C. (2021). Fibroblast growth factor receptors (fgfrs) and noncanonical partners in cancer signaling. Cells, 10.","DOI":"10.3390\/cells10051201"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/14737140.2018.1491795","article-title":"Future applications of fgf\/fgfr inhibitors in cancer","volume":"18","author":"Ghedini","year":"2018","journal-title":"Expert. Rev. Anticancer Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1152\/physrev.00005.2020","article-title":"The fgf\/fgfr system in the physiopathology of the prostate gland","volume":"101","author":"Giacomini","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/med.21855","article-title":"The lymphatic vasculature: An active and dynamic player in cancer progression","volume":"42","author":"Rezzola","year":"2022","journal-title":"Med. Res. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of fgfr3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/modpathol.2009.46","article-title":"Fgfr3 mutations in prostate cancer: Association with low-grade tumors","volume":"22","author":"Agell","year":"2009","journal-title":"Mod. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.humpath.2009.11.003","article-title":"8p11 myeloproliferative syndrome: A review","volume":"41","author":"Jackson","year":"2010","journal-title":"Hum. Pathol."},{"key":"ref_48","first-page":"8371","article-title":"Fusion of etv6 to fibroblast growth factor receptor 3 in peripheral t-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation","volume":"61","author":"Yagasaki","year":"2001","journal-title":"Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pharmthera.2017.05.013","article-title":"Fibroblast growth factors (fgfs) in cancer: Fgf traps as a new therapeutic approach","volume":"179","author":"Presta","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_50","first-page":"4360","article-title":"Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: Definition of phenotypic groups","volume":"57","author":"Courjal","year":"1997","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1158\/0008-5472.CAN-07-5229","article-title":"Fgfr2-amplified gastric cancer cell lines require fgfr2 and erbb3 signaling for growth and survival","volume":"68","author":"Kunii","year":"2008","journal-title":"Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/JTO.0b013e31826aed28","article-title":"Fgfr1 amplification in squamous cell carcinoma of the lung","volume":"7","author":"Heist","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrd3870","article-title":"The role of tumour-stromal interactions in modifying drug response: Challenges and opportunities","volume":"12","author":"McMillin","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.coi.2018.05.011","article-title":"Dendritic cells in inflammatory angiogenesis and lymphangiogenesis","volume":"53","author":"Bosisio","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/CCO.0000000000000420","article-title":"Paracrine interactions of cancer-associated fibroblasts, macrophages and endothelial cells: Tumor allies and foes","volume":"30","author":"Ronca","year":"2018","journal-title":"Curr. Opin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.7150\/jca.40531","article-title":"Fgf\/fgfr signaling pathway involved resistance in various cancer types","volume":"11","author":"Zhou","year":"2020","journal-title":"J. Cancer"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Mori, S., Tran, V., Nishikawa, K., Kaneda, T., Hamada, Y., Kawaguchi, N., Fujita, M., Saegusa, J., Takada, Y.K., and Matsuura, N. (2013). A dominant-negative fgf1 mutant (the r50e mutant) suppresses tumorigenesis and angiogenesis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057927"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Mori, S., Kodaira, M., Ito, A., Okazaki, M., Kawaguchi, N., Hamada, Y., Takada, Y., and Matsuura, N. (2015). Enhanced expression of integrin alphavbeta3 induced by tgf-beta is required for the enhancing effect of fibroblast growth factor 1 (fgf1) in tgf-beta-induced epithelial-mesenchymal transition (emt) in mammary epithelial cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0137486"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"4388","DOI":"10.1242\/jcs.010744","article-title":"Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor","volume":"120","author":"Francavilla","year":"2007","journal-title":"J. Cell Sci."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10585-012-9555-4","article-title":"L1cam stimulates glioma cell motility and proliferation through the fibroblast growth factor receptor","volume":"30","author":"Mohanan","year":"2013","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ejcb.2016.05.002","article-title":"N-cadherin and fibroblast growth factor receptors crosstalk in the control of developmental and cancer cell migrations","volume":"95","author":"Nguyen","year":"2016","journal-title":"Eur. J. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/0008-5472.CAN-06-3401","article-title":"N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation","volume":"67","author":"Hulit","year":"2007","journal-title":"Cancer Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12964-019-0371-1","article-title":"Differential regulation of fibroblast growth factor receptor 1 trafficking and function by extracellular galectins","volume":"17","author":"Kucinska","year":"2019","journal-title":"Cell Commun. Signal. CCS"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Porebska, N., Latko, M., Kucinska, M., Zakrzewska, M., Otlewski, J., and Opalinski, L. (2018). Targeting cellular trafficking of fibroblast growth factor receptors as a strategy for selective cancer treatment. J. Clin. Med., 8.","DOI":"10.3390\/jcm8010007"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1158\/1078-0432.CCR-14-2329","article-title":"Targeting fgfr signaling in cancer","volume":"21","author":"Touat","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.critrevonc.2017.02.018","article-title":"Fgfr a promising druggable target in cancer: Molecular biology and new drugs","volume":"113","author":"Porta","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2217\/fon-2020-0726","article-title":"Pemigatinib, a potent inhibitor of fgfrs for the treatment of cholangiocarcinoma","volume":"17","author":"Merz","year":"2021","journal-title":"Future Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/1078155220983425","article-title":"Fibroblast growth factor receptor (fgfr) inhibitors: A review of a novel therapeutic class","volume":"27","author":"Weaver","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccell.2015.07.002","article-title":"Long-pentraxin 3 derivative as a small-molecule fgf trap for cancer therapy","volume":"28","author":"Ronca","year":"2015","journal-title":"Cancer Cell"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Rezzola, S., Ronca, R., Loda, A., Nawaz, M.I., Tobia, C., Paganini, G., Maccarinelli, F., Giacomini, A., Semeraro, F., and Mor, M. (2019). The autocrine fgf\/fgfr system in both skin and uveal melanoma: Fgf trapping as a possible therapeutic approach. Cancers, 11.","DOI":"10.3390\/cancers11091305"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1167\/iovs.08-2378","article-title":"Activation of the fgf2\/fgfr1 autocrine loop for cell proliferation and survival in uveal melanoma cells","volume":"50","author":"Babchia","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.2147\/OTT.S136677","article-title":"Fgf2 promotes metastasis of uveal melanoma cells via store-operated calcium entry","volume":"10","author":"Wang","year":"2017","journal-title":"Oncol. Targets Ther."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0301-4738.154367","article-title":"Uveal melanoma: Estimating prognosis","volume":"63","author":"Kaliki","year":"2015","journal-title":"Indian J. Ophthalmol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"e9081","DOI":"10.15252\/emmm.201809081","article-title":"Stromal fibroblast growth factor 2 reduces the efficacy of bromodomain inhibitors in uveal melanoma","volume":"11","author":"Chua","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/1568009618666180425142653","article-title":"The anti-malarial drug artesunate blocks wnt\/beta-catenin pathway and inhibits growth, migration and invasion of uveal melanoma cells","volume":"18","author":"Zheng","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/CMR.0b013e3283005270","article-title":"Prognostic biomarkers in uveal melanoma: Evidence for a stem cell-like phenotype associated with metastasis","volume":"18","author":"Chang","year":"2008","journal-title":"Melanoma Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/CMR.0b013e3282f1d302","article-title":"Expression of wnt5a and its downstream effector beta-catenin in uveal melanoma","volume":"17","author":"Zuidervaart","year":"2007","journal-title":"Melanoma Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1167\/iovs.07-1668","article-title":"Basic fibroblast growth factor impact on retinoblastoma progression and survival","volume":"49","author":"Cebulla","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/archopht.123.3.368","article-title":"Acidic fibroblast growth factor (fgf-1) and fgf receptor 1 signaling in human y79 retinoblastoma","volume":"123","author":"Cinaroglu","year":"2005","journal-title":"Arch. Ophthalmol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Cheng, Y., Zheng, S., Pan, C.T., Yuan, M., Chang, L., Yao, Y., Zhao, M., and Liang, J. (2017). Analysis of aqueous humor concentrations of cytokines in retinoblastoma. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0177337"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/med.21452","article-title":"Tumor angiogenesis revisited: Regulators and clinical implications","volume":"37","author":"Ronca","year":"2017","journal-title":"Med. Res. Rev."},{"key":"ref_82","first-page":"2471","article-title":"Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma","volume":"40","author":"Summanen","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/IAE.0b013e318150d6f0","article-title":"Heterogeneous tumor vasculature in retinoblastoma: Implications for vessel targeting therapy","volume":"28","author":"Jockovich","year":"2008","journal-title":"Retina"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.86.4.448","article-title":"Vascular endothelial growth factor is elevated in ocular fluids of eyes harbouring uveal melanoma: Identification of a potential therapeutic window","volume":"86","author":"Boyd","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e14030","DOI":"10.1097\/MD.0000000000014030","article-title":"Cytokines concentrations in aqueous humor of eyes with uveal melanoma","volume":"98","author":"Cheng","year":"2019","journal-title":"Medicine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1167\/iovs.09-4755","article-title":"Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma","volume":"51","author":"Yang","year":"2010","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archopht.126.7.953","article-title":"Inhibitory effect of bevacizumab on the angiogenesis and growth of retinoblastoma","volume":"126","author":"Lee","year":"2008","journal-title":"Arch. Ophthalmol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1136\/bjo.86.4.440","article-title":"Uveal melanomas express vascular endothelial growth factor and basic fibroblast growth factor and support endothelial cell growth","volume":"86","author":"Boyd","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_89","first-page":"1838","article-title":"Basic fibroblast growth factor is present in cultured human retinoblastoma cells","volume":"28","author":"Schweigerer","year":"1987","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1517\/14728222.2015.1062475","article-title":"The potential of fibroblast growth factor\/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis","volume":"19","author":"Ronca","year":"2015","journal-title":"Expert Opin. Ther. Targets"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Zahra, F.T., Sajib, M.S., and Mikelis, C.M. (2021). Role of bfgf in acquired resistance upon anti-vegf therapy in cancer. Cancers, 13.","DOI":"10.3390\/cancers13061422"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of vegf signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0046-8177(95)90191-4","article-title":"Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma","volume":"26","author":"Mooy","year":"1995","journal-title":"Hum. Pathol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3835\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:47:05Z","timestamp":1760136425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/7\/3835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,30]]},"references-count":93,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,4]]}},"alternative-id":["ijms23073835"],"URL":"https:\/\/doi.org\/10.3390\/ijms23073835","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,30]]}}}